Manidipine-d<sub>4</sub>

Manidipine-d4

CAT N°: 30768
Price:

276.00 234.60

Manidipine-d4 is intended for use as an internal standard for the quantification of manidipine (Item No. 23614) by GC- or LC-MS. Manidipine is a dihydropyridine L- and T-type calcium channel blocker.{39642,39643,39644} It inhibits recombinant rabbit L-type (?1C?2/??1a) and human T-type (?1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; Item No. 24127) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively).{39645,39646} In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol (Item No. 15592) when administered at a dose of 3 mg/kg.{39647,39648} Formulations containing manidipine have been used in the treatment of hypertension.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid, 3-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl-d4] 5-methyl ester
  • Correlated keywords
    • GCMS LCMS deuterium deuterated dihydro pyridine A7 r5 CV 4093 ? ?? 1 H C? 2 ET1 iso proterenol
  • Product Overview:
    Manidipine-d4 is intended for use as an internal standard for the quantification of manidipine (Item No. 23614) by GC- or LC-MS. Manidipine is a dihydropyridine L- and T-type calcium channel blocker.{39642,39643,39644} It inhibits recombinant rabbit L-type (?1C?2/??1a) and human T-type (?1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; Item No. 24127) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively).{39645,39646} In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol (Item No. 15592) when administered at a dose of 3 mg/kg.{39647,39648} Formulations containing manidipine have been used in the treatment of hypertension.

We also advise you